{
  "paper_id": "8198fbb4175a2f90bcb43dafc0a365677c916d77",
  "metadata": {
    "title": "Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens",
    "coda_data_split": "dev",
    "coda_paper_id": 1775,
    "coda_has_expert_labels": false,
    "subset": "noncomm_use_subset"
  },
  "abstract": [
    {
      "original_text": "The diagnosis of viral causes of many infectious diseases is difficult due to the inherent sequence diversity of viruses as well as the ongoing emergence of novel viral pathogens, such as SARS coronavirus and 2009 pandemic H1N1 influenza virus, that are not detectable by traditional methods. To address these challenges, we have previously developed and validated a pan-viral microarray platform called the Virochip with the capacity to detect all known viruses as well as novel variants on the basis of conserved sequence homology",
      "sentences": [
        [
          {
            "segment_text": "The diagnosis of viral causes of many infectious diseases is difficult due to the inherent sequence diversity of viruses as well as the ongoing emergence of novel viral pathogens ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "such as SARS coronavirus and 2009 pandemic H1N1 influenza virus ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "that are not detectable by traditional methods .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "To address these challenges , we have previously developed and validated a pan-viral microarray platform called the Virochip with the capacity to detect all known viruses as well as novel variants on the basis of conserved sequence homology",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "1",
    "sentence_num": "2",
    "segment_num": "4",
    "token_num": "87"
  }
}